#carcinoembryonic antigen

[jcrmhscasereports]

Case of Necrotizing Pancreatitis following COVID-19 Infection by Faezeh Sehatpour in Journal of Clinical Case Reports Medical Images and Health Sciences  

ABSTRACT

New aspects of COVID-19 are increasingly being recognized. Although the virus is mainly known to affect the lungs, involvement of other organs including the heart, liver, gastrointestinal, renal and pancreas is also detected. Acute pancreatitis is detected as one of both the early and late presentations of COVID -19. Cytokine storm or the presence of angiotensin-converting enzyme 2 (ACE2) receptor in pancreatic cells, are both two causes of pancreatic injury in COVID-19 infection. In this study, we reported a 25-year-old man admitted to our department with the impression of necrotizing pancreatitis concomitant with COVID-19 infection. Patient's lab data, imaging and outcomes were documented in full detail.

Abbreviations:

WBC, white blood cell;HB, hemoglobin; MCV, mean corpuscular volume; PLT, platelet; BUN, blood urea nitrogen; Na, sodium; K, potassium; ; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALK.P, alkaline phosphatase; ALB, albumin; LDH, Lactate dehydrogenase ; CPK, creatine phosphokinase; CRP,c-reactive protein; AFP,alpha-fetoprotein; CEA,carcinoembryonic antigen; CA19-9,cancer antigen 19-9; Immunoglobulin G4.

INTRODUCTION

The Covid-19 pandemic is an ongoing pandemic that started in December 2019 and spread rapidly around the word. COVID-19 was caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), first identified in Wuhan, China. So far, more than 200 countries have been affected by the pandemic. (1)

New aspects of COVID-19 are increasingly being recognized. Although the virus is mainly known to affect the lungs, involvement of other organs including the heart, liver, gastrointestinal, renal and pancreas is increasingly being reported. (2)

The involvement of the gastrointestinal system is maybe due to the expression of the angiotensin-converting enzyme2 (ACE2) on the hepatocyte, cholangiocyte and  other parts of the GI tract. (3) In a recent survey, acute pancreatitis was detected as one of both early and late presentations of COVID -19. (4-6) However, it is still unclear whether SARS-COV-2 directly affects pancreatic cells because of ACE2, if it is a cytokine storm which causes pancreatic injury. (7)

We reported a case of COVID-19 with subsequent acute necrotizing pancreatitis.

CASE REPORT

A 25-year-old man without any known medical disease presented to our emergency department with progressive epigastric pain, nausea and vomiting and anorexia one week prior to admission. He has no history of alcohol consumption. He also had a history of admission to another hospital about two weeks ago with a diagnosis of COVID-19 pneumonia. On admission, he has a blood pressure of 115/75 mm HG, a heart rate of 100 beats per minute, a temperature of 37.1 ⁰C and oxygen saturation of 95% while the patient is breathing in the room air. Primary investigations summarized in Table-1. Amylase and lipase were 146 IU/L and 82 IU/L respectively. Nasal swab test for COVID-19 (RT-PCR for SARS-CoV-2) was positive. Abdominal sonography showed markedly prominent pancreas with in homogeneous parenchymal echogenicity and large cystic lesion arising from the pancreas, in favor of acute complicated pancreatitis with pseudo cyst. The gall bladder has a normal size and wall thickness without any gall stones. The pancreatic duct was not dilated.  Due to the finding of abdominal ultra sound, CT scan of abdomen was done on him which revealed an enlarged pancreas with necrosis of the main portion of pancreatic parenchyma. Large cystic lesion measuring 15×7×11 cm in size arising from the pancreatic neck with extension to the right and left side of the abdomen suggestive of large pancreatic pseudo cyst (figure1).  Lung HRCT (low dose) also showed bilateral peripheral ground glass opacities in favor of COVID-19 pneumonia (figure2). According to the findings of a physical exam, laboratory data and clues in imaging immediate management of acute necrotizing pancreatitis (invasive intravenous hydration and pain control) was started for him. He was finally discharged from the hospital with a full recovery.

Table 1: laboratory data

Figure 1: Abdominal CT scan:  large loculated pseudo cystic structure measuring about 158mm*100mm in lesser sac due to post pancreatitis pseudo cyst formation.

Figure 2: lung HRCT: multiple ground glass and bilateral pleural effusion

DISCUSSION

Acute pancreatitis is an acute inflammation of the pancreas characterized by abdominal pain, nausea, vomiting and elevated exocrine pancreatic enzymes; amylase and lipase. Gallstones and chronic alcohol abuse are the most common causes of acute pancreatitis. Viruses are uncommon causes of acute pancreatitis. Pancreatitis has been reported with several viruses, including mumps, coxsackievirus, hepatitis A and B virus, cytomegalovirus, varicella-zoster, herpes simplex and human immunodeficiency virus. (8)

Although we have not conclusively proven the presence of the virus in the pancreas, the causes of COVID-19 and acute pancreatitis and the lack of other clear causes for pancreatitis strengthen the relationship between the two diseases.  In this study, the patient presented with necrotizing COVID-19in 19 in the early post period of COVID-19 infection.

In Fan Wang and colleagues' survey, 52 COVID-19 cases followed and showed that 17% of COVID-19 patients developed pancreatic injury and presented with mild elevated pancreatic enzymes; serum amylase and lipase without clinically severe pancreatitis. The possibility of drug induced acute pancreatitis in patients who have received medication due to COVID-19 is also expressed as one of the reasons for acute pancreatitis in COVID-for19 infection. (9) Saffa Saeed Al Mazrouei and his teammates reported a 24-year-old patient with acute non-necrotizing pancreatitis with concurrent COVID-19. No evidence of pseudo cyst or abscess was detected in his imaging. (10)

Pancreatic damage can be due to the direct effect of the virus on pancreatic cells or indirectly secondary to the immune system. In another study in Wuhan, it showed that ACE2 was expressed in the pancreas higher than the lung in the normal population, indicating that SARS-CoV-2 can bind to ACE2 in the pancreas and cause pancreatic cell damage. (7, 11)

Acute pancreatitis is one of the presentations or complications of COVID-19 infection. Further investigation with samples is needed to reveal the pathophysiology, presentation, treatment and prognosis of acute pancreatitis in COVID-19 infection.

For more information: https://jmedcasereportsimages.org/about-us/

For more submission : https://jmedcasereportsimages.org/

#COVID-19 #Cytokine storm #blood cell;HB #aminotransferase #CRP #c-reactive protein #carcinoembryonic antigen #alpha-fetoprotein #anorexia #RT-PCR for SARS-CoV-2 #HRCT #Faezeh Sehatpour #jcrmhs

[mrfrblogresearch02]

Carcinoembryonic Antigen Market will touch a new level in upcoming year 2027

Market Highlights:

The global carcinoembryonic antigen market Share is expected to grow 6.7% during the forecast period.

Carcinoembryonic Antigen or CEA is a kind of glycoprotein produced by cells of the gastrointestinal tract during foetal development which is involved in cell adhesion. Its level is low in healthy adults. However, high levels of CEA are marked in cancerous conditions. The normal range for CEA in an adult who is non-smoker is estimated to be about <2.5 ng/ml. Similarly, for smokers the level of CEA ranges about <5.0 ng/ml. Therefore, on the basis of CEA profiling a number of cancers including colorectal, pancreatic, breast, lung, and others can be easily diagnosed. It is reported that the CEA based diagnostic assays are mostly used for the detection of colorectal cancer.

Factors such as increasing awareness, technological advancements in the medical sector and proteomics, increasing prevalence of colorectal cancer, and lifestyle changes involving the consumption of junk foods, alcohol, and others provides favourable backgrounds for the market growth.

However, side effects related to the CEA test including unreasonable bleeding followed by blacking out, hematoma, risk of infection, erroneous readings and low healthcare expenditures in middle- and low-income countries is estimated to restrain the market growth during the forecast period.

Market Players:

Some of key players profiled in the report are Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam plc., Biocare Medical, LLC, and Biocare Medical, LLC.

Regional Analysis:

North America leads the global carcinoembryonic antigen market owing to high prevalence of colorectal cancer, increasing obese population, lifestyle changes, and increasing acceptance of new technologies. Moreover, increasing government support for research and development propels the market growth. For instance, in 2015, NIH received USD 1 billion for life science and health-related research and development programs.

Europe stands second in the global antigen typing procedure.  Factors such as advanced treatment facilities, rising skilled medical professionals and increasing prevalence of cancer drives the market within the region. In the year 2012, WHO suggested that cancer is the main cause of premature death in 28 of 53 countries in Europe.

Asia Pacific is expected to be the fastest region in the global carcinoembryonic antigen market. This can be attributed due to the increasing prevalence of gastro-intestinal cancer, rising health awareness, availability of new treatment methods, rising government support. Moreover, growing healthcare expenditure boosts the market.

The Middle East & Africa holds the least share in the market owing to the presence of low income countries and low healthcare expenditure, especially within the African region. Within this region, the Middle East leads the market due to the presence of developed economies like United Arab Emirates, Saudi Arabia, and others. Moreover, developed healthcare infrastructure and rising number of skilled medical professionals fuels the regional market.

Market Segmentation:

The global carcinoembryonic antigen market has been segmented on the basis of application, sampling, and end user.

Based on application, the market has been segmented into colorectal, pancreatic, breast, lung cancer, and others.  

Based on sampling, the market has been segmented into antecubital, peritoneal, pleural, serebrospinal, and others.

Based on the end users, the market has been segmented into hospitals, diagnostic centers, research centers, and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

[phone]

Email: [email protected]

#Carcinoembryonic Antigen Market

[wiseguyresearch]

#Carcinoembryonic Antigen Market

[contentment-of-cats]

Medical reality check

Sometimes I feel as if the time since February 2022 has been a long, strange bad dream. Mom's decline into severe dementia came at the same time I was diagnosed with cancer, with her coming off the rails at the same time I was hospitalized and given the nephrostomy. I met with my oncologist yesterday, and I got a big check.

"I'm sorry that she's gone, but maybe now you can fully focus on your own health."

Having my focus all for myself. There's a concept.

85 percent of the people diagnosed with my type of CRC at stage T4a die. I am one of fifteen percent who survived treatment and surgery and achieved remission. Roughly half of those who start treatment at that stage do not make it to surgery, the stats are worse for those who have to have the resection before chemo and radiation. It is also very likely that this cancer will recur and/or metastasize. As a friend said, I am on the measured mile. It's terrifying, but also freeing.

Doc also said that when I talk about not bouncing back, not getting better as fast as I want, that they treated me with the most aggressive radiochemotherapy and a second round of 5-FU or FOLFOX-5 (called by chemo buddies 'the five fuck yous'). He reminded me that most people could not survive the treatment. He reminded me that I have time and to cherish it. To think about whether I am trying to heal for myself, or to please others. To internalize that I am on pain meds to ease the pain from damage left by my treatment, and that the pressure to get off them and 'be better' is a medical decision - not one that needs to be decided by people who think I shouldn't take oxycodone for pain that can hit a seven or eight on a bad day.

10 is the pain I woke up with after the big surgery in November 22. I woke up screaming. I was on 10mg of oxycodone every four hours for six weeks.I am now on 5mg every eight-twelve hours. I may be taking these along with robaxin and gabapentin for the rest of my life.

For my test results, my white cells are all normal or low normals. I may not rebound since these levels have been steady since the end of December, and will have to take greater care to avoid getting sick. I will get sicker, and stay sick longer. My Carcinoembryonic Antigen test shows me to be under the value that would indicate something starting up. My Natera test ought to be back by mid-next week.

Focusing on my health for the measured mile.

#reality check: cashed #cancer #remission #so tired

[drrajeevkapoor]

Rectal Cancer Surgeon in Chandigarh | Surgery, Treatment

Rectal Cancer Surgery

Rectal Cancer Surgeon in Chandigarh – If you are in a concern of rectal cancer, you need not worry. We are here to solve your problem. Dr. Rajeev Kapoor is an experienced rectal cancer surgeon in Chandigarh who has been performing surgeries on rectal cancer patients for a long time. So, if you are in concern of rectal cancer, you must meet Dr. Rajeev Kapoor.

Rectal cancer: An intricate cancer needing specific professionals

Rectal Cancer Surgeon – Cancer happening in the rectum is called rectal cancer. Rectum is the last several inches of the large intestinal tract beginning at the end of the final sector of colon and ends when it gets to the anal canal and opening. Cancer growth or lump inside the rectum (rectal cancer) as well as cancer growth inside the colon (colon cancer) are referred to with each other as “colorectal cancer.”

Rectal as well as colon cancers cells are treated very differently. This is mainly because the rectum is located in a very limited area, hardly divided from various other organs and also frameworks therefore making surgery to get rid of rectal cancer complicated.

Signs and Symptoms of Rectal Cancer

A modification in digestive tract practices like diarrhea, constipation or both; at times there is more-frequent bowel movements

Dark maroon or bright red blood in feces

Slim stools

A sensation that your bowel does not empty totally

Discomfort in the abdomen

Inexplicable weight-loss

Weakness or exhaustion

Examinations to detect as well as confirm rectal cancer

Rectal cancer can be found throughout a screening examination for intestines cancer or it might be presumed based on signs and symptoms. Nonetheless, specific tests are required to be done to validate cancer and as well as also evaluate the spread of the cancer. These are:

Colonoscopy: Colonoscopy is done by utilizing a long, adaptable tube (colonoscope) attached to a camera and display to see your colon and rectum. If cancer is found in your intestine, biopsy i.e. a small piece with a biopsy forceps is taken. The tissue is sent to a lab to be examined as well as confirm cancer cells, aggressiveness and genetics in the cancer cells. These will certainly figure out the treatment options.

Tests to seek  cancer cells spread:

Complete blood count (CBC). A reduced haemoglobin, recommends that a growth is creating blood loss.

Liver Function Tests. Abnormal degrees of some of these chemicals may suggest that cancer has spread to the liver.

Carcinoembryonic antigen (CEA). Carcinoembryonic antigen (CEA), may be greater than typical in people with colon and rectal cancer. CEA testing is specifically useful in keeping track of success to treatment.

CT Scan or PET Scan: It assists figure out whether rectal cancer has actually infected other organs, such as the liver and lungs.

MRI of the pelvis. An MRI offers an in-depth picture of the muscular tissues, organs and various other cells surrounding a rectal tumor within the pelvis. An MRI also shows the lymph nodes near the rectum and anus and various layers of tissue in the rectal and anal wall. This is a really crucial examination to make a decision the sort of therapy to begin with.

A few other tests might be called for to assess physical fitness for surgery.

Staging of Rectal Cancer

The stages of anal cancer are suggested by an array from stages ranging from 0 to IV. The I stage suggests cancer cells that are restricted to the lining of the wall within the lumen of the rectum and anus. By phase IV, the cancer is thought to be complex and also has actually spread out (spread) to various other areas of the body.

Rectal Cancer Treatment

Rectal and anal cancer therapy typically involves a mix of treatments. Surgery is made use of to cut away the cancer. Various other therapies, such as chemotherapy and also radiation treatment, may be used after or before to decrease the danger that cancer will return or make the surgery possible.

If doctors are concerned that the cancer can’t be gotten rid of totally without removing nearby organs and also structures, a mix of radiation treatment and chemotherapy  treatment as preliminary treatment is advised. These combined treatments reduce the cancer and make it easier to eliminate throughout an operation.

Rectal Cancer Surgery

Surgical procedure is the mainstay of therapy. Which procedure is applicable relies on a particular situation, such as the area as well as stage of cancer, aggressiveness of the cancer cells, general health, and occasionally choices.

Workflow used to treat rectal cancer consist of:

Extremely small  cancers may be gotten rid of utilizing a colonoscope or another specialized sort of scope placed via the rectum (trans anal regional excision). This is utilized in limited scenarios or to get rid of polyps. In some cases, after the biopsy is back, we suggest additional surgical procedure.

Bigger rectal cancers that are far sufficient far from the anal opening are eliminated in a procedure (anterior resection) that removes all or part of the rectum. Nearby tissue and also lymph nodes are additionally eliminated. This treatment protects the rectum to make sure that waste can leave the body generally.

For rectal and anal cancers  that are located near the anal opening, it is not possible to remove the cancer completely without damaging the muscular tissues that control defecation. In these scenarios, we advise a procedure called abdominoperineal resection (APR) to get rid of the anus, rectum and also some part of the colon, along with nearby tissues and also lymph nodes. An opening in the abdominal area is developed and also affixes the remaining colon (colostomy). Waste is discharged with the opening and also accumulates in a bag that affixes to abdomen.

#rectalcancersurgeoninchandigarh #coloncancersurgeoninchandigarh #roboticsurgeoninchandigarh #coloncancersurgery

[drpriya]

CA-125 marker is primarily associated with ovarian cancer. Elevated levels of CA-125 are often detected in women with ovarian cancer, particularly in cases of epithelial ovarian cancer, which is the most common type of ovarian cancer.

Apart from ovarian cancer, elevated CA-125 levels can sometimes be found in other types of cancers such as endometrial cancer, fallopian tube cancer, and peritoneal cancer. However, it's most commonly used in the diagnosis and monitoring of ovarian cancer.

In addition to CA-125, several other markers can be used to diagnose and monitor cancer in females, depending on the type of cancer being investigated.

Some common tumor markers include:

CA 15-3: This marker is associated with breast cancer. It is often used to monitor the progression of breast cancer and response to treatment.

CA 19-9: CA 19-9 is associated with pancreatic cancer, but it can also be elevated in other gastrointestinal cancers, including stomach and bile duct cancers.

CEA (Carcinoembryonic Antigen): CEA is a marker used for various cancers, including colorectal cancer, but it can also be elevated in other cancers such as lung, breast, pancreatic, and gastric cancers.

AFP (Alpha-Fetoprotein): AFP is primarily associated with liver cancer (hepatocellular carcinoma) and certain types of germ cell tumors, including testicular cancer and ovarian cancer.

CA 27.29: This marker is used primarily for monitoring breast cancer, especially in cases of metastatic disease.

HE4 (Human Epididymis Protein 4): HE4 is a marker associated with ovarian cancer, particularly in combination with CA-125, to improve the accuracy of diagnosis and monitoring.

These tumor markers are used in conjunction with other diagnostic tests and medical evaluations to help detect cancer, monitor treatment response, and assess disease progression.

The inclusion of CA-125 marker testing in a full body checkup depends on various factors including the individual's medical history, risk factors, and the specific protocol of the full body checkup being performed.

In general, CA-125 testing is not typically included in routine full body checkups for the general population. However, for women who are at higher risk for ovarian cancer due to factors such as family history, certain genetic mutations, or personal medical history, CA-125 testing may be recommended as part of a more comprehensive screening regimen.

Ultimately, the decision to include CA-125 testing in a full body checkup should be made in consultation with a healthcare provider who can assess the individual's risk factors and determine the appropriate screening tests based on current guidelines and evidence-based practices.

Get the best cancer diagnosis and treatment, along with a full body health checkup done at the best hospitals in India.

#health #surgery #healthcare #ovarian cancer #polycystic ovarian disease #CA 125 #cancer marker #full body health checkup #health checkups

[fitjourneydaily]

Understanding the Connection Between the National Institute of Allergy and Infectious Diseases, HerpaGreens, LSD-1 Protein, and TCP: A Comprehensive Guide

Introduction --------------------------------- In the field of healthcare, research and development play a pivotal role in combating various diseases. The National Institute of Allergy and Infectious Diseases (NIAID) is at the forefront of this mission, working tirelessly to improve our understanding of infectious diseases and allergies. Today, we'll delve into the intriguing connection between NIAID, HerpaGreens, the LSD-1 protein, and TCP, exploring how they intersect and contribute to advancements in disease prevention and treatment. Understanding the Role of the National Institute of Allergy and Infectious Diseases (NIAID) (200 words) --------------------------------- The National Institute of Allergy and Infectious Diseases, a part of the National Institutes of Health, is dedicated to research that leads to a better understanding of the immune system and its response to allergies and infectious diseases. NIAID's work encompasses developing new vaccines, therapies, and diagnostic tools, with a relentless focus on the prevention and treatment of various diseases such as HIV/AIDS, influenza, and tuberculosis. HerpaGreens: A Revolutionary Approach in Disease Prevention --------------------------------- In recent years, the world has seen a surge in natural and holistic approaches to disease prevention. One such breakthrough is HerpaGreens, a unique product formulated to address the herpes simplex virus (HSV) outbreak that affects millions of individuals worldwide. Developed in collaboration with NIAID, HerpaGreens combines powerful and natural ingredients to boost the immune system and suppress the HSV virus. By leveraging the expertise of NIAID researchers, HerpaGreens provides a safe and effective alternative for individuals affected by this common viral infection. The Role of the LSD-1 Protein in Disease Progression and Treatment --------------------------------- Recent studies have shed light on the significance of the Lysine-specific Demethylase 1 (LSD-1) protein in disease progression and treatment. LSD-1 plays a critical role in regulating gene expression, cellular differentiation, and organism development. Researchers at NIAID are exploring the potential of LSD-1 inhibitors as a promising therapeutic approach for various diseases, including chronic viral infections and even certain types of cancer. By inhibiting the action of LSD-1, scientists aim to control the progression of diseases and enhance the effectiveness of existing treatments. TCP: A Target for Innovative Therapies --------------------------------- T-cell immunoglobulin and mucin-domain-containing protein 3 (TIM-3) and Carcinoembryonic Antigen Cell Adhesion Molecule 1 (CEACAM1)-related protein (TCP) are emerging as potential targets for innovative therapies. Researchers at NIAID are actively investigating the role of TCP in regulating immune responses and its association with chronic viral infections. By studying the interactions between TCP and other immune checkpoints, scientists aim to develop novel therapeutics that can modulate immune responses and enhance the body's defense against infectious diseases and allergies. Conclusion --------------------------------- The National Institute of Allergy and Infectious Diseases stands as an invaluable organization in the quest for improved healthcare. Collaborations with entities like HerpaGreens, combined with exploring the potential of proteins like LSD-1 and TCP, pave the way for groundbreaking advancements in disease prevention and treatment. Through ongoing research efforts, NIAID continues to unravel the intricacies of our immune system, bolstering our ability to combat infectious diseases and allergies more effectively. Seeking effective strategies, insightful information, and community support for managing and overcoming herpes? health? Visit our website for a wealth of resources and guidance on herpes treatment. Discover the revolutionary benefits of HerpaGreens and explore how natural ingredients can transform your health journey. Don't miss out on our comprehensive insights – your path to recovery starts here. Read the full article

[medidectindia]

The Power of Cancer Screening Blood Tests: Early Detection and Finding a Cancer Specialist Near You

Cancer, a formidable adversary, has affected countless lives around the world. However, advancements in medical technology have provided a glimmer of hope in the fight against this devastating disease. Among these medical breakthroughs, cancer screening blood tests stand out as a powerful tool for early detection. In this article, we will delve into the significance of cancer screening blood tests, their role in the detection of cancer, and how they can lead you to find a cancer specialist near you.

Understanding Cancer Screening Blood Tests

Cancer screening blood tests, also known as liquid biopsies or blood-based cancer tests, are non-invasive diagnostic procedures that analyze a person's blood sample to detect the presence of cancer-related biomarkers. These biomarkers can include specific proteins, circulating tumor cells (CTCs), cell-free DNA (cfDNA), or RNA fragments shed by tumors into the bloodstream. The analysis of these biomarkers helps identify the presence of cancer cells or tumor DNA in the body, enabling early detection and potential intervention.

The Significance of Early Detection

Early detection of cancer is crucial as it significantly improves the chances of successful treatment and enhances patient outcomes. Traditional cancer screening methods, such as mammograms, colonoscopies, and Pap smears, have been instrumental in detecting certain types of cancer. However, they may have limitations in terms of invasiveness, inconvenience, and detection at advanced stages.

Cancer screening blood tests offer a promising alternative, especially for individuals at high risk or those with vague symptoms that could indicate cancer. By detecting cancer at its earliest stages, patients have a higher likelihood of receiving less aggressive and more effective treatment options, leading to an improved quality of life and increased survival rates.

Types of Cancer Detected by Blood Tests

Cancer screening blood tests have proven effective in detecting various types of cancer, including but not limited to:

Breast Cancer: Blood tests can identify specific proteins like CA 15-3 and CA 27.29, which may indicate the presence of breast cancer cells.

Prostate Cancer: Prostate-specific antigen (PSA) levels in the blood can be elevated in men with prostate cancer.

Colorectal Cancer: Blood tests can detect CEA (carcinoembryonic antigen) and CA 19-9, which may be elevated in patients with colorectal cancer.

Lung Cancer: Blood tests can identify certain genetic mutations or alterations in the blood that may be associated with lung cancer.

Ovarian Cancer: CA 125, a protein marker, can be detected through blood tests and may be indicative of ovarian cancer.

Pancreatic Cancer: Certain proteins like CA 19-9 may be elevated in individuals with pancreatic cancer.

The Role of Cancer Specialists

Once a cancer screening blood test indicates abnormal results or raises suspicion of cancer, the next crucial step is to consult a cancer specialist. Cancer specialists, also known as oncologists, are medical professionals with specialized training and expertise in diagnosing and treating various types of cancer.

Finding a Cancer Specialist Near You

Finding a qualified and experienced cancer specialist is essential to ensure accurate diagnosis, effective treatment, and compassionate care. Here are some steps to help you find a cancer specialist near you:

Consult with Your Primary Care Physician: If you have undergone a cancer screening blood test or are experiencing concerning symptoms, start by consulting your primary care physician. They can assess your test results and recommend further evaluation if necessary.

Seek Referrals: Your primary care physician can provide referrals to reputable cancer specialists or oncology centers in your area.

Utilize Online Resources: There are several online platforms that provide directories of cancer specialists based on your location and the type of cancer you may be dealing with.

Check for Board Certification: Ensure that the cancer specialist you choose is board-certified and has the necessary credentials and experience in treating your specific type of cancer.

Read Patient Reviews: Reading patient reviews and testimonials can offer valuable insights into the quality of care provided by the cancer specialist.

Consider Second Opinions: If you have received a cancer diagnosis, consider seeking a second opinion from another reputable cancer specialist. This can provide you with additional perspectives and treatment options.

Conclusion

Cancer screening blood tests have emerged as a groundbreaking tool in the early detection of cancer, offering hope for improved outcomes and better patient experiences. By identifying specific biomarkers in the blood, these tests can detect various types of cancer, prompting timely intervention and treatment. Should a cancer screening blood test indicate abnormal results, it is vital to consult a qualified cancer specialist. These experts play a pivotal role in diagnosing and designing personalized treatment plans, leading to the best possible chance of overcoming cancer's challenges. Remember, early detection and access to a cancer specialist near you can make all the difference in the battle against cancer.

#diagnosis of cancer #early cancer detection test #full cancer check #cancer check up #cancer screaning near me #cancer treatment #cancer diagnosis #lung cancer diagnosis #cervical cancer #cancer #chemotherapy

[rohans18]

Carcinoembryonic Antigen (CEA) Market Expected High Growth in Coming Years

Global Carcinoembryonic Antigen (CEA) Market, By Test type (Molecular Tests, Serology Tests), Product Types (CD66a, CD66b, CD66c, CD66d, CD66e, CD66f), Gender (Male, Female), Application (Gastrointestinal Cancer, Colorectal Cancer, Pancreatic Cancer, Breast Cancer, Lung Cancer, Thyroid Cancer, Ovarian Cancer, Others), End-User (Hospitals, Diagnostic Centers, Cancer Centers, Research, Academic Institutes) – Industry Trends and Forecast to 2029.

In the consistent Carcinoembryonic Antigen (CEA) market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about Carcinoembryonic Antigen (CEA) industry. The scope of this market report include but is not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. An influential Carcinoembryonic Antigen (CEA) market report brings precise and exact market research information that drives business into the right direction.

Key Players

Cyanotech Corporation (U.S.)

I.D. - Parry (India) Limited (India)

BlueBioTech International GmbH (Germany)

Algatech Ltd. (Israel)

Tianjin Norland Biotech Co., Ltd. (China)

AlgaeCan Biotech Ltd. (Canada)

AstaReal AB (Sweden)

Yunnan Alphy Biotech Co., Ltd. (China)

Fenchem (China)

Piveg, Inc. (U.S.)

 Browse More Info @ https://www.databridgemarketresearch.com/reports/global-carcinoembryonic-antigen-cea-market

The research studies entailed in the winning Carcinoembryonic Antigen (CEA) market report supports to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share. The strategies underlined here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Carcinoembryonic Antigen (CEA) Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

[periwinklemeanderings]

What shows up in your blood if you have colon cancer?

“Your doctor may also test your blood for a chemical sometimes produced by colon cancers (carcinoembryonic antigen, or CEA). Tracked over time, the level of CEA in your blood may help your doctor understand your prognosis and whether your cancer is responding to treatment.”

https://www.mayoclinic.org/diseases-conditions/colon-cancer/diagnosis-treatment/drc-20353674#:~:text=Your%20doctor%20may%20also%20test,cancer%20is%20responding%20to%20treatment.

[mambasoftwares]

How Do You Know If You Have Cancer in Your Intestines?

Introduction: Cancer is a complex disease that can affect various parts of the body, including the intestines. Detecting cancer in its early stages is crucial for successful treatment. While only a medical professional can provide an accurate diagnosis, there are certain signs and symptoms that may indicate the presence of intestinal cancer. This article aims to provide an overview of common indications and diagnostic methods used to detect cancer in the intestines.

Signs and Symptoms:

Persistent Changes in Bowel Habits: Frequent episodes of diarrhea or constipation, or noticeable changes in stool consistency that last for an extended period.

Abdominal Pain and Cramping: Ongoing or recurring abdominal discomfort, cramps, or bloating that doesn’t subside.

Unexplained Weight Loss: A significant and unintentional loss of weight without any apparent cause or changes in diet or physical activity.

Rectal Bleeding: Blood in the stool or rectal bleeding, which may manifest as bright red blood or dark, tarry stools.

Fatigue and Weakness: Persistent fatigue, weakness, and a general feeling of exhaustion despite adequate rest.

Anemia: A decrease in red blood cells, resulting in fatigue, pale skin, shortness of breath, and dizziness.

Abdominal Mass or Lump: The presence of a palpable mass or lump in the abdominal area.

Diagnostic Methods:

Physical Examination: A healthcare professional may perform a physical examination to check for any abnormalities in the abdomen, such as swelling or masses.

Blood Tests: Blood samples can be analyzed for tumor markers, such as carcinoembryonic antigen (CEA), which may be elevated in cases of intestinal cancer.

Colonoscopy: A colonoscopy involves inserting a thin, flexible tube with a camera into the rectum and colon to visualize any abnormal growths or polyps.

Biopsy: If abnormal tissue is found during a colonoscopy, a biopsy may be performed. This involves taking a small sample of the tissue for further analysis to determine if it is cancerous.

Imaging Tests: Imaging techniques like computed tomography (CT) scans, magnetic resonance imaging (MRI), or positron emission tomography (PET) scans may be used to detect tumors or assess their spread.

When to Seek Medical Attention: If you experience any persistent or concerning symptoms related to your digestive system, it is important to consult a healthcare professional. While these signs may not necessarily indicate intestinal cancer, they warrant medical evaluation to identify the underlying cause and receive appropriate treatment if necessary.

Conclusion: Detecting cancer in the intestines at an early stage significantly improves the chances of successful treatment and recovery. If you notice any persistent changes in bowel habits, unexplained weight loss, rectal bleeding, abdominal pain, or other concerning symptoms, it is essential to seek medical attention promptly. A healthcare professional will conduct a thorough evaluation and perform necessary diagnostic tests to determine the cause of your symptoms and guide you towards appropriate treatment options. Remember, early detection and timely intervention are crucial for effectively managing intestinal cancer.

[originalinfluencergladiator23]

[tumblhero]

[businesspr]

Global Carcinoembryonic Antigen Market Growth, Share, Opportunities, Competitive Analysis, and Forecast 2023 - 2031

The report “Global Carcinoembryonic Antigen Market” provides a powerful basis for assessing the market and identifying with it other basic technicalities. The exam reveals the Carcinoembryonic Antigen market complete evaluation and true components. The study shows a simple overview of the market, which includes apps, blueprints, the structure of the supply chain, and definitions. It also includes…

View On WordPress

[contrerasbirk80]

Improving the College-Going Technique of Nursing Education and learning for African American Students

The prime peroxidase action regarding hemin complexed using intramolecular concurrent G-quadruplex-forming sequences throughout gene promoters (for example c-Myc, VEGF, c-Kit21, HIF-1 alpha, as well as RET) may indicate a prospective mechanism regarding hemin-mediated mobile harm. This particular peroxidase exercise has been proved relevant pertaining to testing G-quadruplex ligands (possible anticancer reagents) employing colorimetric along with Visible discovery techniques.The objective of this research would have been to discover differentially governed genes in THP-1 monocytic tissues exposed to sensitizers and also nonsensitizers and also to check out if this kind of body's genes could be reputable marker pens to have an in vitro predictive means for the particular identification of skin sensitizing substances. Changes in appearance involving 30 genes within the THP-1 mobile or portable line pursuing treatment method along with chemical substances of numerous sensitizing potential (coming from nonsensitizers in order to severe sensitizers) have been evaluated making use of real-time PCR. Affirmation associated with 13 prospect family genes through assessment a lot of chemical substances (a different Twenty two sensitizers and eight nonsensitizers) said that idea involving speak to sensitization probable had been achievable based on evaluation of modifications in three genes: IL8, HMOX1 as well as PAIMP1. In total, alterations in term of the body's genes allowed proper detection associated with sensitization potential associated with Twenty one away from 28 (78%) analyze sensitizers. Your gene appearance ranges within strength teams diverse and also failed to permit calculate involving sensitization potency involving test substances. Connection between these studies suggest which look at adjustments to expression involving suggested biomarkers inside THP-1 cellular material can be quite a valuable design regarding preliminary screening process of chemical compounds to discriminate a good considerable tastes sensitizers coming from nonsensitizers. (C) The year of 2010 Elsevier Eire Limited SANT-1 . Almost all rights set-aside.Human being papillomavirus sort 07 (HPV-16) connected oropharyngeal malignancies take presctiption a substantial improve and restorative techniques are expected. The particular HPV-16 oncogenes E6 and E7 are usually depicted inside HPV-associated malignancies and are able to change individual tonsillar epithelial tissues (HTECs). We used cell-Systematic Development associated with Ligands through Dramatical Enrichment (SELEX) to pick out with regard to RNA aptamers in which created HPV-16 E6/E7-HTECs. Right after A dozen rounds associated with cell-SELEX, a swimming pool regarding aptamers ended up being received which in fact had considerably greater internalization potential (much like 5-fold) straight into E6/E7-HTECs as compared to primary HTECs or fibroblasts. Examination of human aptamers through the pool area pointed out varied internalization into E6/E7-HTECs (1-8-fold when compared with a negative handle). The majority of the person aptamers internalized directly into E6/E7 and first HTECs with similar productivity, although one particular aptamer showed comparable to 3-fold better internalization straight into E6/E7-HTEC5. Aptamers in which internalize straight into tissues may be ideal for providing healing agents to HPV-16 associated malignancies. (C) The year 2013 Elsevier Inc. Almost all privileges set aside.The role associated with carcinoembryonic antigen (CEA) in early detection regarding repeat through the postoperative follow-up regarding intestinal tract most cancers is still uncertain.

#PI3K Inhibitor Library #JNK inhibitor #PD-1/PD-L1 inhibitor #IU1 #Shikonin #Paeoniflorin #Zebularine #Pitavastatin #Caspofungin #Fisogatinib #SANT-1 #Piperlongumine #Pioglitazone #Go6976 #Asunaprevir #StemRegenin 1 #AZD7545 #Mifepristone #EED226 #Adavivint #NSC-9900 #R 41400 #ZK-62711 #MK-1439 #GS 0840 #BMS-232632 #GS5885 #VX-478 #ABT-267 #ABT-450

[marketresearchideas]